← All trials
NCT01082198
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 1, 2002
- Primary completion
- Apr 1, 2010
- Completion date
- —
- First posted
- —
- Last posted
- —
- Enrollment
- 22
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- Maria Sklodowska Curie Children's HospitalLead sponsor
- Maria Sklodowska Curie Children's HospitalOverall official - principal investigator
Drugs studied
- autologous melanoma lysate/klh-pulsed autologous dendritic cell vaccine
- dendritic cell-idiotype-keyhole limpet hemocyanin vaccine
- hla-a1-binding mage-1/mage-3 multipeptide-pulsed autologous dendritic cell vaccine
- hla-a2-binding tyr/mart-1/gp100 multipeptide-pulsed autologous dendritic cell vaccine
- melanoma peptide-pulsed dendritic cells
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.